Aurangabad

Leading for Pharma Company

Post: Area Sales Manager - 5

State Health Society invites applications for filling vacant positions in district level

Post: Pharmacists

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline.

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.

A leading Pharmaceutical Company requires Medical Representative at all the major HQ's in India.

Post: Medical Representative & Area manager

Harman finochem limited is a leading manufacturer of "active pharmaceutical ingredients" situated in Mumbai, India, exporting api globally. The manufacturing facilities comply to cgmp requirements and have been audited by usfda and who Gmp. Besides this, the company has also been accredited by various other regulatory authorities such as cos from edqm, pharmaceutical inspection convention (pic) member countries, tga-Australia.

ABOUT AUTHORS:
MHG Dehgan, Satapathy Asis Amitav*
Y.B.Chavan College of Pharmacy,
Dr. Rafiq Zakaria Campus,
Auranagbad-431001 (MS),
*asish.apharma@gmail.com

ABSTRACT
Nasal route for the administration of drugs is used as an alternative route for the systemic availability of drugs restricted to intravenous administration. This is due to the large surface area, porous endothelial membrane, high total blood flow, the avoidance of first-pass metabolism, and ready accessibility. The nasal administration of drugs, including many biotechnological compounds like hormones, vaccines, peptide and protein drugs to give enhanced bioavailability. Many drug delivery methods for nasal availability of liquid, semisolid and solid formulation are investigated to avail the drugs to treat most CNS diseases (i.e., Parkinson’s disease, Alzheimer’s disease, Migraine attack) because it requires rapid and/or specific targeted delivery of drugs to the brain.
In this review we discuss some factors affecting nasal absorption, bio-availability barriers, and strategies to improve nasal absorption, new developments in nasal dosage form design and applications of nasal drug delivery system and the effects of microspheres, liposomes and other bioadhesive drug delivery systems on nasal drug absorption.